Jun Yin
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jun
Contact Jun, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Symmetry-breaking co-assembly of conjugated molecules boosts perovskite photovoltaics
Abstract In perovskite photovoltaics, self-assembled molecules (SAMs) have demonstrated the ability to enhance interface quality, reduce charge recombination, and improve energy-level alignment. However, most symmetrical molecules for photovoltaic applications tend to self-aggregate, which hinders uniform film formation, reduces the active surface area, and limits interface contact and device efficiency.
Diagnostic performance and antibiotic impact of droplet digital PCR in suspected sepsis: the PROGRESS trial
|
Abstract Currently, tools to dynamically monitor pathogen load and guide antibiotic adjustment in suspected sepsis are limited. In this prospective, multicenter randomized trial (3:1, ddPCR vs standard care), 1,373 patients were followed for 90 days. The primary outcome was diagnostic efficacy; secondary outcomes included mortality and SOFA. ddPCR showed higher detection positivity (54.1% vs 21.6%, p < 2 × 10−16), faster turnaround, and sensitivity of 80.6%.
By Haocheng Zhang, Ke Xin Lin, Xinlei Xu, Qiaoyan Yue, Xiang Li, Xiaohua Chen, Lina Chen, Yan Huang, Ying Ye, Tingting Su, Jingye Pan, Weiqin Li, Shuang xiao, Xiaoxia Geng, Jingjing Zheng, Lijing Jiang, Jie Chen, Shengguo Zhang, Yadi Liu, Jun Yin, Aiming Zhou, Lu Ke, Qiuping Huang, Li Chen, Ting Feng, Ruilan Wang, Jingwen Ai, Wenhong Zhang, Hejuan Du
|
Nature
Verified
Analytical performance evaluation of MAGLUMI HBeAg and anti-HBe chemiluminescence immunoassays and comparison with the Abbott assays
Abstract Background: Hepatitis B e antigen (HBeAg) and its corresponding antibody (anti-HBe) serve as critical serological markers in the evaluation and therapeutic management of Hepatitis B virus (HBV) infection. Study design: This retrospective study was designed to evaluate the performance of the newly CE-marked MAGLUMI HBeAg (CLIA) and MAGLUMI Anti-HBe (CLIA) assays by comparing with Abbott Architect HBeAg and Abbott Architect Anti-HBe assays, respectively.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jun
Contact Jun, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack